Scandinavian ChemoTech AB is a medical technology company, which engages in the development of patented technology platform. It also offers cancer patients access to a new treatment alternative, tumour specific electroporation, available for treatment of both humans and animals. The company was founded by Stefan Mohan Frick, Bertil Persson, and Klaus Gustav Göran Hellers on February 25, 2015 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company